Brisson, M; Edmunds, WJ; (2003) Economic evaluation of vaccination programs: the impact of herd-immunity. Medical decision making, 23 (1). pp. 76-82. ISSN 0272-989X DOI: https://doi.org/10.1177/0272989X02239651 Full text not available from this repository.

Jones, L; Hawkins, N; Westwood, M; Wright, K; Richardson, G; Riemsma, R; (2004) Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. Health technology assessment (Winchester, England), 8 (5). iii, xiii-xvi, 1-143. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2534908

Trotter, CL; Edmunds, WJ; (2002) Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ, 324 (7341). p. 809. ISSN 0959-535X DOI: https://doi.org/10.1136/bmj.324.7341.809